Disclosures: Monica Tincopa: Nothing to Disclose, Lisa Richards: Nothing to Disclose, Rohit Loomba: Eli Lilly and Company: Consultant 1190 REPRESENTATION OF SEX, RACE AND ETHNICITY IN MASH TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS Matheus Souza 1 Lubna Sharif 2 Ivanna Diaz 3 Samira Khalil 4 Xiu-He Lv 5 Alessandro Mantovani 6 Cristiane Villela-Nogueira, 1 School of Medicine, Federal University of Rio de Janeiro, 2 An-Najah National University, Nablus, Palestine, 3 SUNY Downstate Health Sciences University, Brooklyn, NY, United Sta, 4 Universidad de Buenos Aires, Buenos Aires, Argentina, 5 Sichuan University West China Hospital, Sinchuan, China, 6 University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy, Background: Despite efforts by National Institutes of Health and the US Food and Drug Administration to promote diverse participation in trials, randomized controlled trials (RCTs) in several areas have historically underrepresented female, racial and ethnic minorities
10.2174/157015906776359577 177 NimmrichV.EckertA
Therefore, two additional questions arise: do cells that meet the conditions for ferroptosis also undergo apoptosis
Type: Growth Hormone Secretagogue
Entrance to all mentioned places
